KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Non-Current Assets (2016 - 2025)

Gilead Sciences' Non-Current Assets history spans 17 years, with the latest figure at $40.7 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 2.16% year-over-year to $40.7 billion; the TTM value through Dec 2025 reached $161.9 billion, down 0.74%, while the annual FY2025 figure was $40.7 billion, 2.16% up from the prior year.
  • Non-Current Assets reached $40.7 billion in Q4 2025 per GILD's latest filing, roughly flat from $40.7 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $54.2 billion in Q1 2021 to a low of $39.5 billion in Q1 2025.
  • Average Non-Current Assets over 5 years is $46.3 billion, with a median of $47.2 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: surged 77.31% in 2021, then decreased 14.33% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $53.2 billion in 2021, then decreased by 8.37% to $48.7 billion in 2022, then dropped by 5.52% to $46.0 billion in 2023, then dropped by 13.51% to $39.8 billion in 2024, then rose by 2.16% to $40.7 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Non-Current Assets are $40.7 billion (Q4 2025), $40.7 billion (Q3 2025), and $41.0 billion (Q2 2025).